Nephron-Sparing Surgery for Adenocarcinoma in a Renal Allograft

The incidence of malignant tumors in recipients of renal allografts is higher than in the general population. Renal cell carcinoma (RCC) accounts for 4.6% of the tumors in transplanted patients; of them, only 10% are found in transplanted kidneys. Transplantectomy has always been the usual treatment...

Full description

Saved in:

Bibliographic Details
Published in:	Case reports in urology Vol. 2012; no. 2012; pp. 1 - 3
Main Authors:	Vázquez Alonso, Fernando, Cardozo Rodríguez, Enrique, Puche-Sanz, Ignacio, Flores Martin, Jose Francisco, Molina Hernandez, Jose Miguel, Berrio Campos, Raquel, Vicente-Prados, J., Medina Benitez, Antonio, Cózar Olmo, José Manuel
Format:	Journal Article
Language:	English
Published:	Cairo, Egypt Hindawi Puplishing Corporation 01-01-2012 Hindawi Publishing Corporation Hindawi Limited
Subjects:	Case Report
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The incidence of malignant tumors in recipients of renal allografts is higher than in the general population. Renal cell carcinoma (RCC) accounts for 4.6% of the tumors in transplanted patients; of them, only 10% are found in transplanted kidneys. Transplantectomy has always been the usual treatment. However, during the last years, nephron-sparing surgery of the allograft is more frequently done in well-selected cases, and therefore dialysis can be avoided. We report the case of a 37-year-old female patient with renal transplant, diagnosed with a 4.5 cm tumor in the lower pole of the renal allograft. The patient underwent partial nephrectomy successfully. Six years after surgery, there is no evidence of recurrence of the disease and the patient maintains an adequate renal function.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Academic Editors: T. Inamoto, T. Nomura, and S. Takahashi
ISSN:	2090-696X 2090-6978
DOI:	10.1155/2012/692986